Biotechnology News

November 2, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) is pleased to announce that today the National Institute of Health and Clinical Excellence (NICE) has decided to recommend YERVOY® (ipilimumab), which is approved in the...

November 2, 2012

PALO ALTO, Calif. & DEERFIELD, Ill.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq:AFFY) and Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) today announced the presentation of post-hoc sub-group analyses of the EMERALD Phase 3 studies that evaluated...

November 1, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm (NASDAQ:FLDM) today introduced four new integrated fluidic circuits designed to meet the challenges associated with production genomics.

November 1, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, today confirmed terms of an agreement with plaintiffs to resolve Plubell v. Merck, an economic class action lawsuit pending in Missouri state...

November 1, 2012

PITTSBURGH--(BUSINESS WIRE)--A new study reporting an association between ChemoFx® Drug Response Marker results and recurrence free survival (RFS) of cervical cancer patients was presented at the 14th Biennial Meeting of the International...

November 1, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida to release first quarter 2013 financial results November 8 after market close - conference call at 4:30 p.m. ET same day

November 1, 2012

MALVERN, Pa.--(BUSINESS WIRE)--Benten BioServices, a CRO/CSO specializing in the fastest growing segment of the pharmaceuticals industry - regulated biologics - has received new private investment.

November 1, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will report financial results for the third quarter ending September 30, 2012 on Monday, November 5,...

November 1, 2012

LIVINGSTON, N.J.--(BUSINESS WIRE)--Due to severe weather related to Hurricane Sandy, Columbia Laboratories Inc. (Nasdaq: CBRX) has been without power, phone or email since Monday, October 29, 2012. The Company today announced it expects these...

November 1, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Today Furiex reported its financial and operating results for the quarter ended September 30, 2012.
Furiex recorded third quarter milestone revenue of $10.0 million.

November 1, 2012

AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE:GMED), a leading spinal implant manufacturer, today announced its financial results for the quarter ended September 30, 2012. Worldwide sales were $94.8 million, a 12.5% increase from the...

November 1, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will be hosting a webinar to provide an overview of how LINZESS will be reflected in Ironwood’s quarterly income statements following its...

November 1, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex today reported consolidated financial results for the quarter ended September 30, 2012.

November 1, 2012

WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc., a global leader in the manufacture of orthopaedic and biotechnology products, announced today that Biomet Spine has won three of the ten 2012 Spine Technology Awards. The awards are presented annually...

November 1, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) will release its financial results for the quarter ended September 30, 2012, on Wednesday, November 7, 2012 at approximately 4:00 p.m. ET / 1:00 p.m. PT. The announcement...

November 1, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corp., a leader in the development of innovative drug candidates to address significant diseases of the eye, today announced that final data from a Phase 2 clinical trial of trabodenoson,...

November 1, 2012

VALENCIA, Calif.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq: MNKD) today reported financial results for the third quarter ended September 30, 2012. For the third quarter of 2012, total operating expenses were $35.5 million compared to $32.8...

November 1, 2012

BOSTON--(BUSINESS WIRE)--Goodwin Procter has been recognized in 110 national and metropolitan practice areas in the 2013 “Best Law Firms” survey by U.S. News – Best Lawyers and named “Law Firm of the Year” for Biotechnology.

November 1, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that its third quarter 2012 financial results will be released on Thursday, November 8, 2012. BioCryst will host a conference call and...

November 1, 2012

BOSTON--(BUSINESS WIRE)--Stephen M. Weiner, a Member and Chair of the Health Law Practice of Mintz Levin, will moderate a panel at the New England Israel Business Council’s Life Sciences Summit.

November 1, 2012

SAN DIEGO--(BUSINESS WIRE)--Alexandria Real Estate Equities, Inc. (NYSE: ARE), will celebrate today the grand opening of Nautilus, a nearly fully leased, approximately 220,000 square-foot world-class life science campus.

November 1, 2012

FARMINGTON, Conn.--(BUSINESS WIRE)--Watch a total knee replacement on November 8, at 7:00pm EST, using the ConforMIS iTotal G2 patient-specific knee replacement system. Surgeon Gregory M. Martin, MD, will perform the procedure.

November 1, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the 2012 Credit Suisse Healthcare Conference. The live presentation will occur at 1:00 p...

November 1, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--More than one quarter of FDA approvals in 2012 were developed by Bay Area companies, and BayBio will recognize the people and companies that dedicated themselves to bringing these new treatments to...

November 1, 2012

FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. to report third quarter 2012 financial results on November 5.

November 1, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the Encore Multispan Liquid Handling System, featuring an array of unique technological advances in a single instrument. The Encore Multispan Liquid...

November 1, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--i3 Analytics, which provides deep insight into unstructured data and trends so pharmaceutical business development, clinical development, R&D, regulatory and clinical affairs teams

November 1, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dan Lynch named Chairman of Nimbus Discovery

November 1, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--A recent Cutting Edge Information study finds that successful brands base commercialization strategies on products’ targeted patients and physicians, and their needs.

November 1, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ENSEMBLE THERAPEUTICS AND BOEHRINGER INGELHEIM INITIATE COLLABORATION TO DISCOVER MACROCYCLE DRUG CANDIDATES

November 1, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will host an Analyst Day in New York City on Tuesday, December 4, 2012 from 10:30 a.m. to 12:00 p.m. Eastern Time (7:30 a.m. to 9:00 a.m. Pacific Time). The event will...

November 1, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE MKT: NAVB) Third Quarter 2012 Earnings and Business Update Conference Call Invitation, Thursday Nov 8

November 1, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter today announced an exclusive 20-year partnership with Hemobrás to provide hemophilia patients in Brazil greater access to recombinant factor VIII therapy for the treatment of hemophilia A.

November 1, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Pharmatech Associates, a compliance consulting firm serving companies in the pharmaceutical, industries, was selected to help with the Basis of Design (BoD) for a new manufacturing facility in China.

November 1, 2012

LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems announces the delivery of its fifth TriNiobium Core proton accelerator, the powerful proton source that is at the center of the revolutionary MEVION S250 Proton Therapy System.

November 1, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and its subsidiary OrthoCyte Corporation today announced the appointment of Francois Binette, PhD, as OrthoCyte’s Vice President of Research and Business Development. Dr. Binette’s...

November 1, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that the Data and Safety Monitoring Board (DSMB), an independent group of medical experts...

November 1, 2012

NEW YORK & LONDON--(BUSINESS WIRE)--Jefferies today announced that it will host its 2012 Global Healthcare Conference in London on November 14-15. The two-day conference will feature presentations from public and private companies across the...

November 1, 2012

SEATTLE--(BUSINESS WIRE)--Resolve Therapeutics, LLC today announced that the company has raised $5.8 million in a Series B private-equity financing.

November 1, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (NASDAQ: CLDX) today reported financial results for the third quarter ended September 30, 2012. Celldex reported a net loss of $15.0 million, or $0.25 per share, for the third quarter of...

November 1, 2012

TORONTO--(BUSINESS WIRE)--The relatively underpenetrated Middle Eastern markets for peripheral vascular (PV) devices show excellent growth potential.

November 1, 2012

CAMBRIDGE, Mass. & BOTHELL, Wash.--(BUSINESS WIRE)--Millennium and Seattle Genetics, Inc. today announced the initiation of an international phase 3 clinical trial evaluating ADCETRIS as part of a frontline combinat chemotherapy regimen in HL...

November 1, 2012

SAN DIEGO--(BUSINESS WIRE)--Cytori's third quarter earnings call will be Thursday, November 8 at 5:00 PM ET. Dial-In Number: +1.877.402.3914; Conference ID: 42763342. A webcast will be available live and 2 hours after the call.

November 1, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Enters Agreement with GlaxoSmithKline for Phase 2 All-Oral Study of VX-135 and GSK2336805 for the Treatment of Hepatitis C

November 1, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it has entered into a non-exclusive collaboration with Janssen Pharmaceuticals, Inc. to conduct a Phase 2 proof-of-concept study of an all-...

November 1, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a specialty pharmaceutical company focused on the development and commercialization of Feraheme® (ferumoxytol) Injection for intravenous (IV) use to treat iron...

November 1, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today reported results for the quarter ended September 30, 2012. Highlights: Net revenues of $5.0 billion, compared to $4.3 billion in the third quarter of 2011, an...

November 1, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE):   ($ in millions, except per share amounts)       Third-Quarter       Year-to-Date   2012         2011(4)       Change   2012         2011(4)       Change Reported Revenues $ 13,976 $ 16,609 (16...

November 1, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix launches Axiom Biobank Array, a flexible and high-powered solution, for genotyping large sample collections such as those screened at biobanks, genome centers, and core labs